Description
This drug is new short acting atypical antipsychotic requires twice daily dosing.It blocks 5HT1,5HT2,D2,α1,α2, and H1 receptors in the brain but D2 blocking activity is low.
Extrapyramidal and hyperprolactinaemic side effects are minimal
Reviews
There are no reviews yet.